ENG/中
老虎證券
行情
交易
收費
下載
優惠與活動
幫助
TigerAI
學堂
期權訓練營
投資學堂
機構
財富及資產管理人
自營交易機構
介紹經紀商
三方服務商
股權激勵
關於
關於我們
媒體報道
獎項與榮譽
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
生物科技指數ETF-iShares Nasdaq
216.34
+3.81
1.79%
成交量:
88.76萬
成交額:
1.92億
市值:
108.82億
市盈率:
34.28
高:
217.12
開:
213.40
低:
213.22
收:
212.53
52周最高:
217.12
52周最低:
137.09
股本:
5,030.00萬
流通股本:
5,030.00萬
量比:
0.70
換手率:
1.76%
股息:
0.40
股息率:
0.19%
每股收益(TTM):
6.31
每股收益(LYR):
-1.4940
淨資產收益率:
24.54%
總資產收益率:
0.10%
市淨率:
1.34
市盈率(LYR):
-144.81
資料載入中...
總覽
公司
新聞資訊
公告
概念
ETF&股票定投概念
+0.22%
碎股
+0.22%
資金流向
資金流入:
資金流出:
實時
日
周
月
季度
年
新聞資訊
歐盟委員會擴大吉利德Trodelvy®在轉移性三陰性乳腺癌一線治療中的應用範圍,覆蓋所有PD-L1狀態
美股速递
·
08/24
吉利德科學:歐盟批准Trodelvy聯合Keytruda用於一線PD-L1陽性轉移性三陰性乳腺癌
美股速递
·
08/24
美國聯邦貿易委員會(FTC):安進專利申請收購交易受到反壟斷審查。
智通财经
·
08/21
Piper Sandler上調安進目標價至457美元
格隆汇
·
08/21
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrdive.com/hant/stock/IBB"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"IBB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBB\",,,,,undefined,":{"symbol":"IBB","market":"US","secType":"STK","nameCN":"生物科技指數ETF-iShares Nasdaq","latestPrice":216.34,"timestamp":1787678537429,"preClose":212.53,"halted":0,"volume":887556,"delay":0,"changeRate":0.017926880910930233,"floatShares":50300000,"shares":50300000,"eps":6.311863,"marketStatus":"交易中","change":3.81,"latestTime":"08-25 13:22:18 EDT","open":213.4,"high":217.12,"low":213.22,"amount":191696643.65004,"amplitude":0.01835,"askPrice":216.37,"askSize":24,"bidPrice":216.32,"bidSize":20,"shortable":3,"etf":1,"ttmEps":6.311863,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1787688000000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":212.53,"sharesOutstanding":49450000,"nav":213.623549,"aum":10681177450,"dividendRate":0.001867,"bidAskSpread":0.000342,"preHourTrading":{"tag":"盘前","latestPrice":213.19,"preClose":212.53,"latestTime":"09:29 EDT","volume":272,"amount":58020.02352,"timestamp":1787664595037,"change":0.66,"changeRate":0.003105,"amplitude":0.007293},"postHourTrading":{"tag":"盘后","latestPrice":212.52,"preClose":212.53,"latestTime":"19:59 EDT","volume":15864,"amount":3368429.4655,"timestamp":1787615983668,"change":-0.01,"changeRate":-0.000047,"amplitude":0.003178},"volumeRatio":0.697589,"impliedVol":0.2418,"impliedVolPercentile":0.6494},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBB\",,,,,undefined,":{"symbol":"IBB","floatShares":50300000,"roa":"0.10%","roe":"24.54%","lyrEps":-1.493977,"volumeRatio":0.697589,"shares":50300000,"dividePrice":0.4038,"high":217.12,"amplitude":0.01835,"preClose":212.53,"low":213.22,"week52Low":137.09,"pbRate":"1.34","psRate":"261.81","week52High":217.12,"institutionHeld":0,"latestPrice":216.34,"committee":-0.090909,"eps":6.311863,"divideRate":0.001867,"volume":887556,"delay":0,"ttmEps":6.311863,"open":213.4,"prevYearClose":168.77,"prevWeekClose":213.56,"prevMonthClose":186.41,"prevQuarterClose":190.19,"fiveDayClose":203.56,"twentyDayClose":190.52,"sixtyDayClose":172.18},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBB\",params:#limit:5,,,undefined,":[{"date":"2026-06-15","symbol":"IBB","amount":0.023774,"announcedDate":"2026-06-12","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-15","defaultRemindTime":1781530200000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-18","payableDate":"2026-06-15","currency":"USD","dateTimestamp":1781496000000,"payDate":"2026-06-18"},{"date":"2026-03-17","symbol":"IBB","amount":0.121818,"announcedDate":"2026-03-16","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-17","defaultRemindTime":1773754200000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-20","payableDate":"2026-03-17","currency":"USD","dateTimestamp":1773720000000,"payDate":"2026-03-20"},{"date":"2025-12-16","symbol":"IBB","amount":0.183099,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-19"},{"date":"2025-09-16","symbol":"IBB","amount":0.082843,"announcedDate":"2025-09-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-16","defaultRemindTime":1758029400000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-19","payableDate":"2025-09-16","currency":"USD","dateTimestamp":1757995200000,"payDate":"2025-09-19"},{"date":"2025-03-18","symbol":"IBB","amount":0.121169,"announcedDate":"2025-03-17","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-18","defaultRemindTime":1742304600000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-21","payableDate":"2025-03-18","currency":"USD","dateTimestamp":1742270400000,"payDate":"2025-03-21"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBB\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-26","recordDate":"2016-09-28","paymentDate":"2016-09-30","value":0.0858219,"currency":"USD"},{"executeDate":"2016-12-22","recordDate":"2016-12-27","paymentDate":"2016-12-29","value":0.091903,"currency":"USD"},{"executeDate":"2017-03-24","recordDate":"2017-03-28","paymentDate":"2017-03-30","value":0.29898,"currency":"USD"},{"executeDate":"2017-06-27","recordDate":"2017-06-29","paymentDate":"2017-06-30","value":0.176803,"currency":"USD"},{"executeDate":"2017-09-26","recordDate":"2017-09-27","paymentDate":"2017-09-29","value":0.118654,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBB\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBB\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1186632498","title":"歐盟委員會擴大吉利德Trodelvy®在轉移性三陰性乳腺癌一線治療中的應用範圍,覆蓋所有PD-L1狀態","url":"https://stock-news.laohu8.com/highlight/detail?id=1186632498","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186632498?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 18:32","pubTimestamp":1787567559,"startTime":"0","endTime":"0","summary":"欧盟委员会近日作出重要决定,将吉利德科学(Gilead Sciences)旗下重磅药物Trodelvy®的适用范围进一步拓宽。此次调整聚焦于转移性三阴性乳腺癌的一线治疗领域,且不再受限于患者的PD-L1表达状态。这一举措意味着,无论生物标志物检测结果如何,符合条件的患者均有望从该疗法中获益。此举不仅为临床医生提供了更为灵活的用药选择,也标志着Trodelvy®在肿瘤治疗版图中的地位得到显著提升。吉利德科学方面对此表示积极回应,认为该批准将助力满足更多患者未被满足的医疗需求。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBQ","LU1571399168.USD","LU1674673691.USD","LU0965509010.AUD","LU1934455194.USD","LU2087621335.USD","MEDI","LU0965509101.SGD","IE00B19Z3B42.SGD","IE00BKVL7J92.USD","LU2357627491.SGD","LU1585245621.USD","LU2112291526.USD","BK4532","LU0861579265.USD","BK4588","LU1066053197.SGD","LU1430594728.SGD","LU1037948541.HKD","LU0122379950.USD","LU2089984988.USD","LU1934455277.USD","BK4550","BBH","LU0823416689.USD","LU0965509283.SGD","LU0109394709.USD","TMED","SG9999015952.SGD","SG9999015986.USD","LU1057294990.SGD","IE00B19Z3581.USD","IE0002270589.USD","IE00BSNM7G36.USD","LU0889565916.HKD","BMED","BK4578","LU2468319806.SGD","SG9999015945.SGD","LU1934455863.HKD","LU2324357040.USD","LU1037948897.HKD","LU1023059063.AUD","SG9999015978.USD","LU1674673428.USD","BK4139","BIB","LU0114720955.EUR","TBXU","GILD","IE00B7SZLL34.SGD","LU0882574055.USD","BK4568","LU1061106388.HKD","LU1839511570.USD","LU0965508806.USD","LU0289739699.SGD","BK4566","BK4583","BK4585","IBB","IE00B3T34201.USD","LU0234570918.USD","LU0859254822.USD","LU1066051498.USD","LU1778281490.HKD","IE00BZ1G4Q59.USD","LU0320765992.SGD","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193380081","title":"吉利德科學:歐盟批准Trodelvy聯合Keytruda用於一線PD-L1陽性轉移性三陰性乳腺癌","url":"https://stock-news.laohu8.com/highlight/detail?id=1193380081","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193380081?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 18:32","pubTimestamp":1787567533,"startTime":"0","endTime":"0","summary":"吉利德科学公司宣布,欧盟已正式授予其抗体药物偶联物Trodelvy与默沙东的Keytruda联合用药方案的上市许可。这一批准针对的是既往未经治疗的PD-L1阳性转移性三阴性乳腺癌患者群体。此项授权标志着该联合疗法在欧盟地区的临床可及性迈出关键一步,为这类侵袭性强、治疗选择有限的乳腺癌亚型患者提供了新的一线治疗选项。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDI","LU0861579265.USD","LU0965508806.USD","LU1057294990.SGD","LU1066051498.USD","LU1778281490.HKD","LU0965509283.SGD","SG9999015952.SGD","BK4550","BK4585","LU1571399168.USD","LU2112291526.USD","LU1037948897.HKD","LU2357627491.SGD","LU0109394709.USD","LU1839511570.USD","TMED","IE00B3T34201.USD","BMED","BIB","LU1585245621.USD","LU0859254822.USD","BK4568","GILD","IE00B7SZLL34.SGD","IBBQ","LU0289739699.SGD","LU1037948541.HKD","BK4566","LU1674673691.USD","IE00B19Z3B42.SGD","LU0320765992.SGD","TBXU","BBH","LU0234570918.USD","LU2089984988.USD","LU2087621335.USD","LU1061106388.HKD","LU1430594728.SGD","IE00BKVL7J92.USD","LU1066053197.SGD","LU0823416689.USD","LU1934455194.USD","BK4583","LU0965509010.AUD","IE0002270589.USD","LU0058720904.USD","BK4588","LU0882574055.USD","IE00B19Z3581.USD","SG9999015945.SGD","LU0889565916.HKD","LU2324357040.USD","IE00BZ1G4Q59.USD","LU1674673428.USD","LU1934455277.USD","LU1023059063.AUD","LU1934455863.HKD","BK4139","IE00BSNM7G36.USD","LU0122379950.USD","SG9999015986.USD","LU0114720955.EUR","SG9999015978.USD","BK4532","LU2468319806.SGD","BK4578","LU0965509101.SGD","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661291370","title":"美國聯邦貿易委員會(FTC):安進專利申請收購交易受到反壟斷審查。","url":"https://stock-news.laohu8.com/highlight/detail?id=2661291370","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661291370?lang=zh_tw&edition=fundamental","pubTime":"2026-08-21 23:49","pubTimestamp":1787327356,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["FTC","BIB","GXPC","EVNT","JHMT","DISC","PBS","TGRW","PNQI","LRGG","AMGN","IXP","IEME","RSPT","MSFY","XLCI","MNA","WEBL","TBXU","GXPT","GGTL","PJP","TDAQ","BCTK","ORCZ","KEMQ","MRGR","TRUC","WEBX","DRUP","PBE","CWC","QQMG","IHF","FCOM","ONEQ","NBDS","BUYO","IBB","IBBQ","MUSQ","NBCC","MSFX","ARB","BWEB","GOOX","BBH","HCA","JHCS","EMQQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661250489","title":"Piper Sandler上調安進目標價至457美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2661250489","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661250489?lang=zh_tw&edition=fundamental","pubTime":"2026-08-21 15:20","pubTimestamp":1787296801,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["IBBQ","LU1571399168.USD","UDN","IE0002141913.USD","BK4533","IE00BJT1NW94.SGD","SG9999001440.SGD","BK4534","LU2112291526.USD","BK4588","LU0122379950.USD","LU2089984988.USD","PBE","UUP","BBH","PJP","LU0109394709.USD","IE00BJJMRZ35.SGD","LU1983299246.USD","LU1057294990.SGD","LU0889565916.HKD","BK4599","LU2468319806.SGD","IE00BFTCPJ56.SGD","LU2242652126.USD","LU1023059063.AUD","IE00B4R5TH58.HKD","LU0868494617.USD","BK4139","BIB","TBXU","LU1061106388.HKD","IE0009355771.USD","BK4581","LU0289739699.SGD","BK4566","IBB","BK4585","LU2242646821.SGD","AMGN","LU0320765992.SGD","IE00B2B36J28.USD","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":38,"pageCount":1,"totalSize":150,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/IBB\",params:#limit:6,delay:false,,,undefined,":[{"market":"US","name":"ETF&股票定投概念","id":"package_us_concept_etf&gpdt","bkCode":"BK4585","changeRate":0.002235},{"market":"US","name":"碎股","id":"package_us_concept_sg","bkCode":"BK4588","changeRate":0.00225}]}}